Mirador Therapeutics, Inc.
Mirador Therapeutics, Inc. is a clinical-stage precision medicine company focused on developing first-and/or best-in-class next-generation therapeutics for immunology and inflammation. The company’s Mirador360™ precision development engine leverages the latest advances in human genetics and data science to rapidly deliver new precision medicines for patients living with immune-mediated inflammatory and fibrotic diseases. Mirador has raised over $650 million from leading life sciences investors and is based in San Diego, CA. Mirador was named Best Places to Work by BioSpace and is a Great Place to Work-Certified™ Company. For more information, please visit us at www.miradortx.com and follow us on LinkedIn.
Mirador’s values reflect how we operate every day—as individuals, as teams and as a company shaping the future of patient care.
We trust each other to deliver, to be accountable and to always have each other’s backs.
We think boldly, act fearlessly and turn big ideas into real impact for patients.
We listen, learn and solve together—because we’re stronger as one team.
We do what’s right, guided by science, ethics and purpose in everything we do.
We set the bar high and keep raising it, driving collective success through shared standards.
We take pride in our work, our impact and the company we’re building together.
